The global medical industry experienced a 28% decline in the number of social responsibility-related patent applications in Q1 2024 compared with the previous quarter. The total number of social responsibility-related grants dropped by 20% in Q1 2024, according to GlobalData’s Patent Analytics. GlobalData’s databook Medical Devices: Patents Trends Q1 2024 offers comprehensive insights into patenting trends, major players’ strategies, and geographical focus in the sector over the last three years. Buy the databook here.
Notably, the number of social responsibility-related patent applications in the medical industry was 83 in Q1 2024, versus 115 in the prior quarter.
The top five companies accounted for 8% of patenting activity
Analysis of patenting activity by companies shows that Paul Hartmann filed the most social responsibility patents within the medical industry in Q1 2024. The company filed 2 social responsibility-related patents in the quarter. It was followed by Central China Normal University with 2 social responsibility patent filings, DL (1 filing), and Delta Galil Industries (1 filing) in Q1 2024.
See Also:
Patenting activity was driven by the US with a 43% share of total patent filings
The largest share of social responsibility related patent filings in the medical industry in Q1 2024 was in the US with 43%, followed by China (19%) and Japan (16%). The share represented by the US was 9% higher than the 34% share it accounted for in Q4 2023.
For further understanding of GlobalData's Medical Devices: Patents Trends Q1 2024, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.